| Net Cash Provided by (Used in) Operating Activities |
$4,954,200 |
USD |
-1299% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$152,587 |
USD |
-69% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$1,829,194 |
USD |
-199% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
600,000,000 |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
48,720,405 |
shares |
740% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$6,630,807 |
USD |
-1320% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$6,663,463 |
USD |
52% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$2,001,367 |
USD |
60% |
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
$2,001,367 |
USD |
60% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
20,000,000 |
shares |
1900% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$230,932,280 |
USD |
3456% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
$1,600,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |